C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1

Abstract Background Small nucleolar RNAs (snoRNAs) are dysregulated in many cancers, although their exact role in tumor genesis and progression remains unclear. Methods The expression profiles of snoRNAs in endometrial cancer (EC) tissues were analyzed using data from The Cancer Genome Atlas, and SN...

Full description

Bibliographic Details
Main Authors: Bingfeng Lu, Xi Chen, Xin Liu, Jingwen Chen, Honglei Qin, Shuo Chen, Yang Zhao
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-022-03802-z
_version_ 1797977261503152128
author Bingfeng Lu
Xi Chen
Xin Liu
Jingwen Chen
Honglei Qin
Shuo Chen
Yang Zhao
author_facet Bingfeng Lu
Xi Chen
Xin Liu
Jingwen Chen
Honglei Qin
Shuo Chen
Yang Zhao
author_sort Bingfeng Lu
collection DOAJ
description Abstract Background Small nucleolar RNAs (snoRNAs) are dysregulated in many cancers, although their exact role in tumor genesis and progression remains unclear. Methods The expression profiles of snoRNAs in endometrial cancer (EC) tissues were analyzed using data from The Cancer Genome Atlas, and SNORD104 was identified as an upregulated snoRNA in EC. The tumorigenic role of SNORD104 in EC was established in CCK8, colony formation, EdU, apoptosis, Transwell, and in vivo xenograft experiments. The molecular mechanisms of SNORD104 were analyzed by RNA immunoprecipitation (RIP), Nm-seq, RTL-P assay, RNA stability assay, qRT-PCR, and western blotting. Results Antisense oligonucleotide (ASO)-mediated knockdown of SNORD104 in Ishikawa cells significantly inhibited their proliferation, colony formation ability, migration, and invasion in vitro and increased apoptosis. On the other hand, overexpression of SNORD104 promoted EC growth in vivo and in vitro. RIP assay showed that SNORD104 binds to the 2ʹ-O-methyltransferase fibrillarin (FBL), and according to the results of Nm-seq and RTL-P assay, SNORD104 upregulated PARP1 (encoding poly (ADP-ribose) polymerase 1) 2ʹ-O-methylation. The binding of FBL to PARP1 mRNA was also verified by RIP assay. Furthermore, SNORD104 expression was positively correlated with PARP1 expression in EC tissues. In the presence of actinomycin D, SNORD104 increased the stability of PARP1 mRNA and promoted its nuclear localization. Finally, silencing FBL or PARP1 in the HEC1B cells overexpressing SNORD104 inhibited their proliferative and clonal capacities and increased apoptosis rates. Conclusions SNORD104 enhances PARP1 mRNA stability and translation in the EC cells by upregulating 2ʹ-O-methylation and promotes tumor growth.
first_indexed 2024-04-11T05:04:10Z
format Article
id doaj.art-65c90b16e0704c1e9511d31b91e9db46
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-11T05:04:10Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-65c90b16e0704c1e9511d31b91e9db462022-12-25T12:27:29ZengBMCJournal of Translational Medicine1479-58762022-12-0120111410.1186/s12967-022-03802-zC/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1Bingfeng Lu0Xi Chen1Xin Liu2Jingwen Chen3Honglei Qin4Shuo Chen5Yang Zhao6Department of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Gynecologic Oncology Research Office, Guangdong Provincial Key Laboratory for Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityAbstract Background Small nucleolar RNAs (snoRNAs) are dysregulated in many cancers, although their exact role in tumor genesis and progression remains unclear. Methods The expression profiles of snoRNAs in endometrial cancer (EC) tissues were analyzed using data from The Cancer Genome Atlas, and SNORD104 was identified as an upregulated snoRNA in EC. The tumorigenic role of SNORD104 in EC was established in CCK8, colony formation, EdU, apoptosis, Transwell, and in vivo xenograft experiments. The molecular mechanisms of SNORD104 were analyzed by RNA immunoprecipitation (RIP), Nm-seq, RTL-P assay, RNA stability assay, qRT-PCR, and western blotting. Results Antisense oligonucleotide (ASO)-mediated knockdown of SNORD104 in Ishikawa cells significantly inhibited their proliferation, colony formation ability, migration, and invasion in vitro and increased apoptosis. On the other hand, overexpression of SNORD104 promoted EC growth in vivo and in vitro. RIP assay showed that SNORD104 binds to the 2ʹ-O-methyltransferase fibrillarin (FBL), and according to the results of Nm-seq and RTL-P assay, SNORD104 upregulated PARP1 (encoding poly (ADP-ribose) polymerase 1) 2ʹ-O-methylation. The binding of FBL to PARP1 mRNA was also verified by RIP assay. Furthermore, SNORD104 expression was positively correlated with PARP1 expression in EC tissues. In the presence of actinomycin D, SNORD104 increased the stability of PARP1 mRNA and promoted its nuclear localization. Finally, silencing FBL or PARP1 in the HEC1B cells overexpressing SNORD104 inhibited their proliferative and clonal capacities and increased apoptosis rates. Conclusions SNORD104 enhances PARP1 mRNA stability and translation in the EC cells by upregulating 2ʹ-O-methylation and promotes tumor growth.https://doi.org/10.1186/s12967-022-03802-zSNORD1042ʹ-O-methylationFibrillarinPARP1Endometrial cancer
spellingShingle Bingfeng Lu
Xi Chen
Xin Liu
Jingwen Chen
Honglei Qin
Shuo Chen
Yang Zhao
C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
Journal of Translational Medicine
SNORD104
2ʹ-O-methylation
Fibrillarin
PARP1
Endometrial cancer
title C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
title_full C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
title_fullStr C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
title_full_unstemmed C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
title_short C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2ʹ-O-methylation of PARP1
title_sort c d box small nucleolar rna snord104 promotes endometrial cancer by regulating the 2 o methylation of parp1
topic SNORD104
2ʹ-O-methylation
Fibrillarin
PARP1
Endometrial cancer
url https://doi.org/10.1186/s12967-022-03802-z
work_keys_str_mv AT bingfenglu cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT xichen cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT xinliu cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT jingwenchen cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT hongleiqin cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT shuochen cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1
AT yangzhao cdboxsmallnucleolarrnasnord104promotesendometrialcancerbyregulatingthe2ʹomethylationofparp1